Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer

Autor: Lynda Wyld, Richard Simcock, Jacqui Gath, Alan Brennan, Deirdre Revell, Maria Burton, Riccardo A. Audisio, Jay Naik, Malcolm W.R. Reed, Kwok L. Cheung, Geoffrey Holmes, Charlene Martin, Annaliza Todd, Matthew Hatton, Tim Chater, Kirsty Pemberton, Stephen J Walters, Chris Holcombe, Matthew C Winter, Margot Gosney, Thompson G. Robinson, Kate Lifford, Adrian Edwards, A. Ring, Anne Shrestha, Kieran Horgan, Sue Ward, Juliet Wright, Alastair M. Thompson, Karen Collins, Rishi Parmeshwar, Nicolò Matteo Luca Battisti, Esther Herbert, Jenna Morgan, Age Gap Tmg, Tracey Green, Mike Bradburn

Publikováno v: European Journal of Cancer

Introduction Older patients with early breast cancer (EBC) derive modest survival benefit from chemotherapy but have increased toxicity risk. Data on the impact of chemotherapy for EBC on quality of life in older patients are limited, but this is a k

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c68c8fa09c8aa22242569bec59d7264
http://europepmc.org/articles/PMC7896040

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer.

Autor: Ring A; Department of Medicine, Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK & Breast Cancer Research Division, The Institute of Cancer Research, London, UK., Battisti NML; Department of Medicine, Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK & Breast Cancer Research Division, The Institute of Cancer Research, London, UK., Reed MWR; Brighton and Sussex Medical School, Brighton, UK., Herbert E; Clinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK., Morgan JL; Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK., Bradburn M; Clinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK., Walters SJ; Clinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK., Collins KA; College of Health, Wellbeing and Life Sciences, Department of Allied Health Professions, Sheffield Hallam University, Sheffield, UK., Ward SE; Department of Health Economics and Decision Science, School for Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK., Holmes GR; Department of Health Economics and Decision Science, School for Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK., Burton M; College of Health, Wellbeing and Life Sciences, Department of Allied Health Professions, Sheffield Hallam University, Sheffield, UK., Lifford K; Division of Population Medicine, Cardiff University, Cardiff, UK., Edwards A; Division of Population Medicine, Cardiff University, Cardiff, UK., Robinson TG; Department of Cardiovascular Sciences and NIHR Biomedical Research Centre, University of Leicester, Cardiovascular Research Centre, Leicester, UK., Martin C; Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK., Chater T; Clinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK., Pemberton KJ; Clinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK., Brennan A; Department of Health Economics and Decision Science, School for Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK., Cheung KL; School of Medicine, University of Nottingham, Royal Derby Hospital, Derby, UK., Todd A; Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK., Audisio RA; University of Gothenberg, Sahlgrenska Universitetssjukhuset, Göteborg, Sweden., Wright J; Brighton and Sussex Medical School, Brighton, UK., Simcock R; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK., Green T; Yorkshire and Humber Consumer Research Panel, Cottingham, UK., Revell D; Yorkshire and Humber Consumer Research Panel, Cottingham, UK., Gath J; Yorkshire and Humber Consumer Research Panel, Cottingham, UK., Horgan K; Department of Breast Surgery, Bexley Cancer Centre, St James's University Hospital, Leeds, UK., Holcombe C; Liverpool University Hospitals Foundation Trust, Liverpool, UK., Winter MC; Weston Park Hospital, Sheffield, UK., Naik J; Pinderfields Hospital, Mid Yorkshire NHS Foundation Trust, Wakefield, UK., Parmeshwar R; University Hospitals of Morecambe Bay, Royal Lancashire Infirmary, Lancaster, Lancashire, UK., Gosney MA; Royal Berkshire NHS Foundation Trust, Reading, UK., Hatton MQ; Weston Park Hospital, Sheffield, UK., Thompson AM; Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Wyld L; Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK. l.wyld@sheffield.ac.uk.

Publikováno v: British journal of cancer [Br J Cancer] 2021 Jul; Vol. 125 (2), pp. 209-219. Date of Electronic Publication: 2021 May 10.

Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021.

Autor: Li, Jianbin, Zhou, Jifang, Wang, Haibo, Liu, Zhenzhen, Fan, Zhimin, Liu, Yinhua, Geng, Cuizhi, Xiao, Yue, Jiang, Zefei

Publikováno v: JAMA Network Open; 6/30/2023, Vol. 6 Issue 6, pe2321388-e2321388, 1p